{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:20:41Z","timestamp":1774441241867,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"DOI":"10.7759\/cureus.72363","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T12:16:43Z","timestamp":1729858603000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea"],"prefix":"10.7759","author":[{"given":"Jessie M","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel K","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Fahlstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P","family":"Troost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda R","family":"Helfrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Rosacea","author":"Farshchian M","year":"2024","unstructured":"Farshchian M, Daveluy S. Rosacea. StatPearls (Internet). StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.0526","article-title":"Assessment of frequency of rosacea subtypes in patients with rosacea: a systematic review and meta-analysis","volume":"158","author":"Barakji YA","year":"2022","unstructured":"Barakji YA, R\u00f8nnstad AT, Christensen MO, et al.. Assessment of frequency of rosacea subtypes in patients with rosacea: a systematic review and meta-analysis. JAMA Dermatol. 2022, 158:617-25. 10.1001\/jamadermatol.2022.0526","journal-title":"JAMA Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.055","article-title":"Evidence-based update on rosacea comorbidities and their common physiologic pathways","volume":"78","author":"Holmes AD","year":"2018","unstructured":"Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang AL. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol. 2018, 78:156-66. 10.1016\/j.jaad.2017.07.055","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two AM","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015, 72:749-60. 10.1016\/j.jaad.2014.08.028","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2050640614559262","article-title":"Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea","volume":"3","author":"Gravina A","year":"2015","unstructured":"Gravina A, Federico A, Ruocco E, et al.. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United Eur Gastroenterol J. 2015, 3:17-24. 10.1177\/2050640614559262","journal-title":"United Eur Gastroenterol J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.054","article-title":"Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication","volume":"6","author":"Parodi A","year":"2008","unstructured":"Parodi A, Paolino S, Greco A, et al.. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008, 6:759-64. 10.1016\/j.cgh.2008.02.054","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00460-1","article-title":"Rosacea and the microbiome: a systematic review","volume":"11","author":"Daou H","year":"2021","unstructured":"Daou H, Paradiso M, Hennessy K, Seminario-Vidal L. Rosacea and the microbiome: a systematic review. Dermatol Ther. 2021, 11:1-12. 10.1007\/s13555-020-00460-1","journal-title":"Dermatol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01624-x","article-title":"Rosacea, germs, and bowels: a review on gastrointestinal comorbidities and gut-skin axis of rosacea","volume":"38","author":"Wang FY","year":"2021","unstructured":"Wang FY, Chi CC. Rosacea, germs, and bowels: a review on gastrointestinal comorbidities and gut-skin axis of rosacea. Adv Ther. 2021, 38:1415-24. 10.1007\/s12325-021-01624-x","journal-title":"Adv Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank L","year":"1999","unstructured":"Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999, 34:870-7. 10.1080\/003655299750025327","journal-title":"Scand J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin J","year":"2004","unstructured":"Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004, 50:907-12. 10.1016\/j.jaad.2004.01.048","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.i18","article-title":"The 13C urea breath test in the diagnosis of Helicobacter pylori infection","volume":"45","author":"Savarino V","year":"1999","unstructured":"Savarino V, Vigneri S, Celle G. The 13C urea breath test in the diagnosis of Helicobacter pylori infection. Gut. 1999, 45:I18-22. 10.1136\/gut.45.2008.i18","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.09.055","article-title":"Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy","volume":"12","author":"Saad RJ","year":"2014","unstructured":"Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol. 2014, 12:1964-72. 10.1016\/j.cgh.2013.09.055","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000103892","article-title":"Small intestinal bacterial overgrowth: diagnosis and treatment","volume":"25","author":"Gasbarrini A","year":"2007","unstructured":"Gasbarrini A, Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V, Gasbarrini G. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis. 2007, 25:237-40. 10.1159\/000103892","journal-title":"Dig Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/131.10.2789S","article-title":"Helicobacter pylori: ulcers and more: the beginning of an era","volume":"131","author":"Lacy BE","year":"2001","unstructured":"Lacy BE, Rosemore J. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr. 2001, 131:2789S-93S. 10.1093\/jn\/131.10.2789S","journal-title":"J Nutr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0065-1","article-title":"A systematic review of diagnostic tests for small intestinal bacterial overgrowth","volume":"53","author":"Khoshini R","year":"2008","unstructured":"Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008, 53:1443-54. 10.1007\/s10620-007-0065-1","journal-title":"Dig Dis Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206017","article-title":"How to recognize and treat small intestinal bacterial overgrowth?","volume":"11","author":"Skrzyd\u0142o-Radoma\u0144ska B","year":"2022","unstructured":"Skrzyd\u0142o-Radoma\u0144ska B, Cukrowska B. How to recognize and treat small intestinal bacterial overgrowth?. J Clin Med. 2022, 11:6017. 10.3390\/jcm11206017","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12030","article-title":"Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation","volume":"21","author":"Casas C","year":"2012","unstructured":"Casas C, Paul C, Lahfa M, et al.. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 2012, 21:906-10. 10.1111\/exd.12030","journal-title":"Exp Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.08.006","article-title":"Potential role of microorganisms in the pathogenesis of rosacea","volume":"69","author":"Holmes AD","year":"2013","unstructured":"Holmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol. 2013, 69:1025-32. 10.1016\/j.jaad.2013.08.006","journal-title":"J Am Acad Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7110550","article-title":"The skin and gut microbiome and its role in common dermatologic conditions","volume":"7","author":"Ellis SR","year":"2019","unstructured":"Ellis SR, Nguyen M, Vaughn AR, Notay M, Burney WA, Sandhu S, Sivamani RK. The skin and gut microbiome and its role in common dermatologic conditions. Microorganisms. 2019, 7:550. 10.3390\/microorganisms7110550","journal-title":"Microorganisms"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201600008","article-title":"The gut-skin axis in health and disease: a paradigm with therapeutic implications","volume":"38","author":"O'Neill CA","year":"2016","unstructured":"O'Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: a paradigm with therapeutic implications. Bioessays. 2016, 38:1167-76. 10.1002\/bies.201600008","journal-title":"Bioessays"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(08)80863-8","article-title":"Substance P and rosacea","volume":"28","author":"Powell FC","year":"1993","unstructured":"Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993, 28:132-3. 10.1016\/s0190-9622(08)80863-8","journal-title":"J Am Acad Dermatol"},{"key":"ref22","article-title":"Helicobacter pylori in patients with rosacea","volume":"89","author":"Rebora A","year":"1994","unstructured":"Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol. 1994, 89:1603-4.","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4321\/s1130-01082006000700003","article-title":"Effect of Helicobacter pylori eradication therapy in rosacea patients","volume":"98","author":"Boixeda de Miquel D","year":"2006","unstructured":"Boixeda de Miquel D, V\u00e1zquez Romero M, V\u00e1zquez Sequeiros E, et al.. Effect of Helicobacter pylori eradication therapy in rosacea patients. Rev Esp Enferm Dig. 2006, 98:501-9. 10.4321\/s1130-01082006000700003","journal-title":"Rev Esp Enferm Dig"},{"key":"ref24","article-title":"The role of Helicobacter pylori in rosacea and pathogenetic treatment","volume":"298","author":"Beridze L","year":"2020","unstructured":"Beridze L, Ebanoidze T, Katsitadze T, Korsantia N, Zosidze N, Grdzelidze N. The role of Helicobacter pylori in rosacea and pathogenetic treatment. Georgian Med News. 2020, 298:109-12.","journal-title":"Georgian Med News"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01452.x","article-title":"The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea","volume":"41","author":"G\u00fcrer MA","year":"2002","unstructured":"G\u00fcrer MA, Erel A, Erba\u015f D, Ca\u011flar K, Atahan C. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol. 2002, 41:768-70. 10.1046\/j.1365-4362.2002.01452.x","journal-title":"Int J Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.26719\/2003.9.1-2.167","article-title":"Helicobacter pylori and rosacea","volume":"9","author":"Zandi S","year":"2003","unstructured":"Zandi S, Shamsadini S, Zahedi MJ, Hyatbaksh M. Helicobacter pylori and rosacea. East Mediterr Health J. 2003, 9:167-71.","journal-title":"East Mediterr Health J"},{"key":"ref27","article-title":"Helicobacter pylori and its eradication in rosacea","volume":"50","author":"Szlachcic A","year":"1999","unstructured":"Szlachcic A, Sliwowski Z, Karczewska E, Biela\u0144ski W, Pytko-Polonczyk J, Konturek SJ. Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol. 1999, 50:777-86.","journal-title":"J Physiol Pharmacol"},{"key":"ref28","article-title":"Serologic determination of Helicobacter pylori in rosacea patients and controls","volume":"21","author":"Schneider MA","year":"1992","unstructured":"Schneider MA, Skinner RB, Rosenberg EE, et al.. Serologic determination of Helicobacter pylori in rosacea patients and controls. Clin Res. 1992, 21:831A.","journal-title":"Clin Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00220.x","article-title":"A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea","volume":"93","author":"Sharma VK","year":"1998","unstructured":"Sharma VK, Lynn A, Kaminski M, Vasudeva R, Howden CW. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol. 1998, 93:220-2. 10.1111\/j.1572-0241.1998.00220.x","journal-title":"Am J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(99)70493-7","article-title":"Helicobacter pylori eradication treatment reduces the severity of rosacea","volume":"40","author":"Uta\u015f S","year":"1999","unstructured":"Uta\u015f S, Ozbakir O, Turasan A, Uta\u015f C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol. 1999, 40:433-5. 10.1016\/s0190-9622(99)70493-7","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02852.x","article-title":"The response of rosacea to eradication of Helicobacter pylori","volume":"140","author":"Son SW","year":"1999","unstructured":"Son SW, Kim IH, Oh CH, Kim JG. The response of rosacea to eradication of Helicobacter pylori. Br J Dermatol. 1999, 140:984-5. 10.1046\/j.1365-2133.1999.02852.x","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2000.15.5.551","article-title":"Relationship between Helicobacter pylori and rosacea: it may be a myth","volume":"15","author":"Herr H","year":"2000","unstructured":"Herr H, You CH. Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci. 2000, 15:551-4. 10.3346\/jkms.2000.15.5.551","journal-title":"J Korean Med Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310016544","article-title":"Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study","volume":"83","author":"Diaz C","year":"2003","unstructured":"Diaz C, O'Callaghan CJ, Khan A, Ilchyshyn A. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol. 2003, 83:282-6. 10.1080\/00015550310016544","journal-title":"Acta Derm Venereol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01144.x","article-title":"Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?","volume":"19","author":"Gedik GK","year":"2005","unstructured":"Gedik GK, Karaduman A, Sivri B, Caner B. Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?. J Eur Acad Dermatol Venereol. 2005, 19:398-9. 10.1111\/j.1468-3083.2005.01144.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03424.x","article-title":"Clinical and laboratory study of rosacea in northern Greece","volume":"24","author":"Lazaridou E","year":"2010","unstructured":"Lazaridou E, Apalla Z, Sotiraki S, Ziakas NG, Fotiadou C, Ioannides D. Clinical and laboratory study of rosacea in northern Greece. J Eur Acad Dermatol Venereol. 2010, 24:410-4. 10.1111\/j.1468-3083.2009.03424.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012080.pub2","article-title":"Non-invasive diagnostic tests for Helicobacter pylori infection","volume":"3","author":"Best LM","year":"2018","unstructured":"Best LM, Takwoingi Y, Siddique S, et al.. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018, 3:CD012080. 10.1002\/14651858.CD012080.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00090-3.x","article-title":"Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association","volume":"14","author":"Bonamigo RR","year":"2000","unstructured":"Bonamigo RR, Leite CS, Wagner M, Bakos L. Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association. J Eur Acad Dermatol Venereol. 2000, 14:424-5. 10.1046\/j.1468-3083.2000.00090-3.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01817.x","article-title":"Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients","volume":"42","author":"Argenziano G","year":"2003","unstructured":"Argenziano G, Donnarumma G, Iovene MR, et al.. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol. 2003, 42:601-4. 10.1046\/j.1365-4362.2003.01817.x","journal-title":"Int J Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.11.038","article-title":"Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin","volume":"68","author":"Weinstock LB","year":"2013","unstructured":"Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin. J Am Acad Dermatol. 2013, 68:875-6. 10.1016\/j.jaad.2012.11.038","journal-title":"J Am Acad Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14930","article-title":"Rosacea and gastrointestinal disorders: a population-based cohort study","volume":"176","author":"Egeberg A","year":"2017","unstructured":"Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017, 176:100-6. 10.1111\/bjd.14930","journal-title":"Br J Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01085","article-title":"Regulation of lung immunity and host defense by the intestinal microbiota","volume":"6","author":"Samuelson DR","year":"2015","unstructured":"Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol. 2015, 6:1085. 10.3389\/fmicb.2015.01085","journal-title":"Front Microbiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/s1438-422180002-3","article-title":"Virulence factors of Helicobacter pylori","volume":"290","author":"Dundon WG","year":"2001","unstructured":"Dundon WG, de Bernard M, Montecucco C. Virulence factors of Helicobacter pylori. Int J Med Microbiol. 2001, 290:647-58. 10.1016\/s1438-422180002-3","journal-title":"Int J Med Microbiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01459","article-title":"The gut microbiome as a major regulator of the gut-skin axis","volume":"9","author":"Salem I","year":"2018","unstructured":"Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018, 9:1459. 10.3389\/fmicb.2018.01459","journal-title":"Front Microbiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3232-4","article-title":"Relationship between Helicobacter pylori and rosacea: review and discussion","volume":"18","author":"Yang X","year":"2018","unstructured":"Yang X. Relationship between Helicobacter pylori and rosacea: review and discussion. BMC Infect Dis. 2018, 18:318. 10.1186\/s12879-018-3232-4","journal-title":"BMC Infect Dis"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14352","article-title":"Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis","volume":"31","author":"J\u00f8rgensen AR","year":"2017","unstructured":"J\u00f8rgensen AR, Egeberg A, Gideonsson R, Weinstock LB, Thyssen EP, Thyssen JP. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017, 31:2010-5. 10.1111\/jdv.14352","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13985","article-title":"Effects of the treatment for small intestine bacterial overgrowth on rosacea","volume":"44","author":"Drago F","year":"2017","unstructured":"Drago F, Ciccarese G, Parodi A. Effects of the treatment for small intestine bacterial overgrowth on rosacea. J Dermatol. 2017, 44:e321. 10.1111\/1346-8138.13985","journal-title":"J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280109-evaluation-of-helicobacter-pylori-and-small-intestinal-bacterial-overgrowth-in-subjects-with-rosacea","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T12:16:46Z","timestamp":1729858606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280109-evaluation-of-helicobacter-pylori-and-small-intestinal-bacterial-overgrowth-in-subjects-with-rosacea"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.72363","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}